Quick Answer
NeuroSense Therapeutics Ltd. reported Shares Outstanding of 32.56 million shares for fiscal year 2025.
NeuroSense Therapeutics Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 32.56M | +40.2% |
| 2024 | 23.23M | +51.0% |
| 2023 | 15.38M | — |
- NeuroSense Therapeutics Ltd. showed an increase of +40.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, NeuroSense Therapeutics Ltd.’s shares outstanding has grown by 111.7% (from 15.38 million shares to 32.56 million shares).
- The most recent figure is from NeuroSense Therapeutics Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: